focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Spree D Regulatory News (PSDL)

Share Price Information for Phoenix Spree D (PSDL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 155.00
Bid: 152.00
Ask: 155.00
Change: 0.00 (0.00%)
Spread: 3.00 (1.974%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 155.00
PSDL Live PriceLast checked at -
Phoenix Spree Deutschland is an Investment Trust

To provide Shareholders with both stable income returns, as well as capital growth through investment in German real estate, with a focus on residential properties in Berlin and secondary German cities.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

First Day of Dealings

15 Jun 2015 07:00

RNS Number : 1052Q
Phoenix Spree Deutschland Limited
15 June 2015
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA, OR ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

 

15 June 2015

Phoenix Spree Deutschland Limited

First Day of Dealings

Phoenix Spree Deutschland Limited (the "Company") is pleased to announce the admission of the Company's ordinary shares (the "Shares") to the premium listing segment of the Official List of the Financial Conduct Authority and the commencement of dealings on the London Stock Exchange plc's Main Market for listed securities at 8.00 am today ("Admission").

The total number of ordinary shares in the Company in issue immediately following Admission is 69,872,298 each with equal voting rights. This total voting rights figure can be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest in the Company under the Disclosure and Transparency Rules of the Financial Conduct Authority.

The Shares will trade under the TIDM PSDL (ISIN: JE00B248KJ21).

ENQUIRIES

For further information, please contact:

PMM Partners (Property Advisor) Mike Hilton

Matthew Northover

Paul Ruddle

Stuart Young

 

+44 (0)20 8973 1020

Liberum (Sponsor) Richard Crawley

Christopher Britton

 

+44 (0)20 3100 2222

Bell Pottinger (Financial Public Relations)

Victoria Geoghegan

Jo Boon

Nick Lambert

 

+44 (0)20 3772 2500

 

IMPORTANT INFORMATION

This announcement does not constitute or form part of, and should not be construed as, an offer to sell or issue, or a solicitation of any offer to buy or subscribe for, any securities, nor shall it or any part of it, or the fact of its distribution, form the basis of, or be relied on in connection with, any contract or commitment whatsoever. This announcement does not constitute a recommendation regarding any securities. Investors should not subscribe for or purchase any securities referred to in this announcement except on the basis of information in the prospectus published by the Company on 10 June 2015, and any supplement thereto.

 

Liberum, which is authorised and regulated in the United Kingdom by the FCA, is acting exclusively for the Company and for no-one else in connection with Admission and the arrangements referred to in this announcement and is not acting for nor will it be responsible to any other person in connection with Admission including for providing the protections afforded to clients of Liberum or for providing advice in connection with Admission, the contents of this announcement or any matters referred to in this announcement. Liberum is not responsible for the contents of this announcement. Liberum has not authorised the contents of, or any part of, this announcement and no liability whatsoever is accepted by Liberum nor does it make any representation or warranty, express or implied, for the accuracy of any information or opinion contained in this announcement or for the omission of any information. Liberum disclaims all and any responsibility or liability whether arising in tort, contract or otherwise which it might otherwise have in respect of this announcement. This does not exclude or limit any responsibilities which Liberum may have under FSMA or the regulatory regime established thereunder.

 

The distribution of this announcement and other documents and/or information in connection with the Admission in other jurisdictions may be restricted by law and therefore neither this announcement nor any other documents and/or information in connection with Admission may be published, distributed or transmitted by any means or media directly or indirectly, in whole or in parts in or into any jurisdiction except under circumstances that will result in compliance with any applicable laws and regulations. Persons into whose possession any document and/or other information referred to herein comes should inform themselves about and observe any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdictions. This announcement does not constitute an offer to sell or the solicitation of an offer to buy securities in any jurisdiction in which such offer would be unlawful. In particular, this announcement does not constitute an offer to buy securities, and it is not for distribution, directly or indirectly, in or into the United States of America, Canada, Australia, the Republic of South Africa, or Japan.

 

The Shares have not been, and will not be, registered under the United States Securities Act 1933 (as amended) nor under the securities laws or with any securities regulatory authority of any state or other jurisdiction of the United States of America or of any province or territory of Canada, Australia, the Republic of South Africa or Japan, nor in any country or territory where to do so may contravene local securities laws or regulations and will not be made to any national, resident or citizen of the United States of America, Canada, Australia, the Republic of South Africa or Japan. In addition, the Company has not been, and will not be, registered under the United States Investment Company 1940 (as amended).

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUSRRRVOANAUR
Date   Source Headline
30th Apr 20247:00 amRNS2023 full-year results and condominium strategy
15th Mar 20247:00 amRNSSale of Multi-Family Property and Condominiums
13th Mar 20248:34 amRNSStatement Re Share Price Movement
28th Feb 20247:00 amRNSQSix Germany appoints Christian Daumann as CEO
7th Feb 20247:00 amRNSBusiness update and Portfolio valuation
31st Jan 20242:42 pmRNSHolding(s) in Company
8th Jan 20247:00 amRNSTermination of forward funding commitment
17th Oct 20237:00 amRNS2023 Interim Financial Report Correction
27th Sep 20237:00 amRNSInterim Results for 6 months ended 30 June 2023
17th Aug 20234:23 pmRNSCompletion of Amended PAIR
3rd Aug 20237:00 amRNSInvestment Property Valuation and Business Update
28th Jun 20233:39 pmRNSResult of AGM
5th Jun 20237:00 amRNSAGM & Property Advisor Proposal
31st May 20235:39 pmRNSChange of Registered Office
29th Mar 20237:00 amRNSFinal Results for the year ended 31 December 2022
1st Mar 20234:35 pmRNSPrice Monitoring Extension
7th Feb 20237:00 amRNSInvestment Property Valuation and Business Update
11th Jan 20237:00 amRNSDirectorate Change
21st Oct 20225:17 pmRNSHolding(s) in Company
29th Sep 20227:00 amRNSInterim Results for 6 months ended 30 June 2022
22nd Aug 20224:18 pmRNSDeath of a Non-executive Director – Greg Branch
4th Aug 20227:00 amRNSPortfolio valuation as at 30 June 2022
1st Jul 20227:00 amRNSTransaction in Own Shares
30th Jun 20227:00 amRNSTransaction in Own Shares
28th Jun 20221:45 pmRNSTransaction in Own Shares
27th Jun 20227:00 amRNSTransaction in Own Shares
24th Jun 20227:00 amRNSTransaction in Own Shares
23rd Jun 20227:00 amRNSTransaction in Own Shares
22nd Jun 20227:00 amRNSTransaction in Own Shares
21st Jun 20227:00 amRNSTransaction in Own Shares
20th Jun 20227:00 amRNSTransaction in Own Shares
17th Jun 20227:00 amRNSTransaction in Own Shares
16th Jun 20227:00 amRNSTransaction in Own Shares
15th Jun 20224:29 pmRNSResult of AGM
15th Jun 20227:00 amRNSTransaction in Own Shares
14th Jun 20227:00 amRNSTransaction in Own Shares
13th Jun 20227:00 amRNSTransaction in Own Shares
9th Jun 20227:00 amRNSTransaction in Own Shares
9th Jun 20227:00 amRNSAnnual General Meeting
8th Jun 20227:00 amRNSTransaction in Own Shares
7th Jun 20227:00 amRNSTransaction in Own Shares
6th Jun 20227:00 amRNSTransaction in Own Shares
1st Jun 20227:00 amRNSTransaction in Own Shares
31st May 20227:00 amRNSTransaction in Own Shares
30th May 20227:00 amRNSTransaction in Own Shares
27th May 20227:00 amRNSTransaction in Own Shares
26th May 20227:00 amRNSTransaction in Own Shares
25th May 20227:00 amRNSTransaction in Own Shares
24th May 20222:25 pmRNSNotice of AGM
24th May 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.